Broadcom: A Golden Buying Opportunity

Broadcom's custom AI silicon business is seeing surging demand, and the company delivered a Q2 '26 earnings and revenue beat. Semiconductor Solutions revenue grew 79% year over year, while free cash flow rose 60% to $10.3B with a 46% FCF margin. However, shares fell more than 12% because AI chip revenue guidance was left unchanged, tempering the otherwise strong operating results.

Analysis

The selloff looks more like an expectations reset than a deterioration in fundamentals. The market is signaling that AI monetization at scale still needs proof, but the underlying economics suggest this is a rare case where a platform supplier is already converting demand into cash at unusually high rates; that matters because hyperscaler AI capex tends to be lumpy, while custom silicon programs create longer-duration design wins and stickier share. The second-order winner is likely the ecosystem around AVGO’s supply chain: advanced packaging, substrate, and test capacity remain the real bottlenecks, so any incremental acceleration in orders should leak first into those constrained upstream names before it is fully reflected in AVGO’s revenue guide.

The key risk is not demand collapse, but timing mismatch. If the current guide remains conservative for another quarter or two, the stock can continue to derate even as fundamentals improve, because AI investors are paying for re-acceleration, not just delivery. Over a months-long horizon, the setup improves materially if management can point to either a new hyperscaler customer, faster ramp at existing customers, or clearer visibility into 2027 AI silicon revenue; absent that, the market may treat the business as a very profitable but not yet compounding AI franchise.

The move is arguably overdone relative to free-cash-flow durability. A business generating this level of cash with this margin profile usually trades less like a pure-play AI hardware name and more like a high-quality platform compounder once the growth scare passes. Consensus may be underestimating how quickly “unchanged guidance” can become a very favorable setup if the next print shows even modest upside surprise against a reset base.

Watch for a technical capitulation window over the next 1-2 weeks: if the stock stabilizes after the post-earnings flush, the risk/reward shifts toward owning the reset. The cleanest read-through is whether peers in AI networking, packaging, and test equipment stop underperforming; that would imply the market is moving from questioning demand to worrying about capacity, which is usually a much better regime for the whole chain.

Key Decisions for Investors

• Buy AVGO on weakness over the next 1-2 weeks, targeting a 3-6 month hold; use the post-earnings gap as the entry if it consolidates, with upside tied to any guide-up or customer commentary that re-accelerates AI revenue expectations.
• Pair trade: long AVGO / short a basket of lower-quality AI hardware beneficiaries that trade purely on narrative rather than cash generation; this captures the spread if the market rotates back toward durable FCF and away from speculative growth.
• For more convex exposure, buy 3-6 month AVGO call spreads after the volatility spike normalizes; structure for a 1:2 to 1:3 risk/reward if the stock retraces part of the post-print move and then rerates on next-quarter visibility.
• Monitor upstream bottlenecks and consider a long basket in advanced packaging/substrate/test names if AVGO order flow appears to be constrained by supply rather than demand; these names can respond first over the next 1-3 months.